Top Medical News from Across Medscape

  • Tenecteplase: Thrombolytic of Choice in Stroke?The EXTEND-IA TNK trial suggesting better outcomes with tenecteplase than alteplase in the treatment of acute ischemic stroke has now been published in the New England Journal of Medicine.
  • CMS to Recast 'Meaningful Use' Data Reporting RulesMedicare officials also are using the update of an annual payment to compel hospitals to put their standard charges on the Internet and to address price of costly CAR T cancer treatment.

Special Report

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California